Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Inventory 2019-2026 | MRNA

Annual FY2019–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$153.0M

+30.8%YoY vs FY2024Source: 10-KFY2025

From $0 in FY2019 to $153.0M in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$146M+14.1%Not reportedNot reportedNot reported
FY25$128M−56.6%$240M−39.8%$332M−19.4%$153M+30.8%
FY24$295M−59.7%$399M−44.2%$412M−15.4%$117M−42.1%
FY23$732M−62.3%$715M−62.8%$487M−76.6%$202M−78.7%
FY22$1.9B+293.1%$1.9B+198.8%$2.1B+115.2%$949M−34.1%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+26.6%

FY2020
$47.0M
FY2025
$153.0M

5 years selected · on the chart

Inventory History

Year-over-year comparison from 10-K annual reports

  1. $153.0M
YoY changeLargest recent move+2966.0%in FY21Latest +30.8%

1 older move runs past ±150% (largest +2966.0%); point at, tap or drag across the bars to read one.

Inventory, period by period

PeriodValueChangeSource
FY2025$153.0M+30.8%10-K
FY2024$117.0M−42.1%10-K
FY2023$202.0M−78.7%10-K
FY2022$949.0M−34.1%10-K
FY2021$1.44B+2966.0%10-K
FY2020$47.0M—10-K
FY2019$0—10-K

What is inventory?

Inventory includes raw materials, work-in-progress, and finished goods held for sale in the ordinary course of business.

What is Moderna, Inc.'s current inventory?

Moderna, Inc. (MRNA) annual inventory for 2025 was $153.0M, a 30.77% increase from 2024. Moderna, Inc. inventory for the quarter ending March 31, 2026 was $146.0M.

What was Moderna, Inc.'s inventory in 2024?

Moderna, Inc. annual inventory for 2024 was $117.0M, a 42.08% decline from 2023.

What was Moderna, Inc.'s inventory in 2023?

Moderna, Inc. annual inventory for 2023 was $202.0M, a 78.71% decline from 2022.

What is Moderna, Inc.'s 5-year inventory CAGR?

Moderna, Inc. inventory grew at a compound annual growth rate (CAGR) of 26.62% from FY2020 to FY2025, going from $47.0M to $153.0M over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)